Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501783PMID: 30000842
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 873857-62-6
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of fidaxomicin during breastfeeding. Because it is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Fidaxomicin
CAS Registry Number
873857-62-6
Drug Class
Breast Feeding
Lactation
Anti-Infective Agents
Macrocyclic Antibiotics
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis.[Antibiotics (Basel). 2017]Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis.Serra S, Malpezzi L, Bedeschi A, Fuganti C, Fonte P. Antibiotics (Basel). 2017 Feb 8; 6(1). Epub 2017 Feb 8.
- Review Ioversol.[Drugs and Lactation Database (...]Review Ioversol.. Drugs and Lactation Database (LactMed®). 2006
- Review Iohexol.[Drugs and Lactation Database (...]Review Iohexol.. Drugs and Lactation Database (LactMed®). 2006
- Total synthesis of the tiacumicin B (lipiarmycin A3/fidaxomicin) aglycone.[Angew Chem Int Ed Engl. 2015]Total synthesis of the tiacumicin B (lipiarmycin A3/fidaxomicin) aglycone.Glaus F, Altmann KH. Angew Chem Int Ed Engl. 2015 Feb 2; 54(6):1937-40. Epub 2014 Dec 15.
- Review Iopromide.[Drugs and Lactation Database (...]Review Iopromide.. Drugs and Lactation Database (LactMed®). 2006
- Fidaxomicin - Drugs and Lactation Database (LactMed®)Fidaxomicin - Drugs and Lactation Database (LactMed®)
- Chain G, Inner core structural protein VP3Chain G, Inner core structural protein VP3gi|1720273178|pdb|6PNS|GProtein
Your browsing activity is empty.
Activity recording is turned off.
See more...